cagrisema cagrilintide semaglutide phase 3 obesity Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Novo Nordisk's CagriSema outperforms Ozempic

Most patients need a series of treatments spaced several weeks apart, with the exact schedule depending on how your retina responds

All of these with a free at-home blood test before anything is prescribed, and a real clinician making your dose decisions based on your results, not a quiz

SGLT-2 inhibitors (like empagliflozin and dapagliflozin) increase urinary glucose levels, creating conditions that promote bacterial growth and have documented associations with UTIs and genital infections

Always consult with a qualified healthcare professional for personalized guidance based on your medical history and current medications

Understanding Semaglutide Semaglutide is an injectable medication commonly used to manage type 2 diabetes and assist with weight loss in individuals with obesity

Does GLP-1 make adhering to low carbs easier